The Nonclinical Sciences team works enthusiastically and collaboratively to solve problems in drug development, partnering with colleagues in other Translational Sciences teams, Research, and the greater Development organization. At Seagen, our teams are empowered to think creatively to navigate the drug development pathway from discovery to marketing. The successful candidate will join a rapidly growing and evolving company that offers unlimited opportunities for career development in a friendly and fun environment.

Principle Responsibilities:

• Serve as study anatomic pathologist or peer review pathologist on non-GLP and GLP toxicology studies, conducting anatomic evaluation of tissues and data, integrating findings into pathophysiologic understanding of toxicities from early stages through registration and post-marketing.
• Lead the design, conduct, and interpretation of pathology endpoints on nonclinical studies, including mechanistic/investigative studies.
• Demonstrate critical thinking in departmental and cross-departmental discussions and meetings.
• Interpret and communicate findings to cross-functional project teams and senior management.
• Participate in regulatory submission document preparation and scientific publications, including addressing queries from global health authorities.
• Design and execute plans for issue resolution for regulatory and mechanistic studies.
• Serve as a nonclinical representative on research and development project teams and provide guidance on business development opportunities.
• Appropriately engage internal and external experts to resolve development and regulatory issues.
• Effectively collaborate with and mentor other drug development scientists in a multidisciplinary environment and within a highly matrixed reporting structure.

Required Qualifications:

• 0-2 years of accounting experience in a manufacturing environment.

Required Qualification:

• DVM, VMD, or equivalent degree with advanced education and training in Veterinary Anatomic Pathology.
• Certification in Veterinary Pathology required (e.g. ACVP, JCVP, MRCPath, ECVP, or equivalent).
• PhD in a relevant scientific discipline is preferred but not required.
• 8+ years of work experience in Toxicologic Pathology in the pharmaceutical/biotechnology sector from early to late-stage programs, including the conduct of GLP peer reviews, serving as project team representative and developing novel approaches to address regulatory challenges.
• Demonstrated effectiveness as a team player on drug development projects.
• Demonstrated excellence in oral and written communication skills, including authorship of regulated pathology reports.

As the leading employer in our industry in the Pacific Northwest, Seagen is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seagen, visit www.seagen.com.

Seagen is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.

To prevent the spread of COVID-19, and as an integral part of its public health and safety measures, Seagen requires that all newly-hired employees be fully vaccinated against COVID-19 before commencing employment, subject to reasonable accommodation and other requirements of applicable federal, state, and local law.

Apply:

Seagen

Seagen is an Equal Opportunity Employer

Submitted: 06/10/2022